Although employees showing COVID-19 symptoms are currently discouraged from going to work, significant workplace COVID-19 outbreaks were recently reported. Virus spread by asymptomatic SARS-CoV-2 infected individuals has been reported to be a significant cause of contamination clusters. Yet, other than PCR testing every employee each day using an invasive nasal or nasopharyngeal swab, few options … [Read more...] about Eurofins publishes method for early detection of asymptomatic SARS-CoV-2 virus spreaders, that does not require human PCR clinical testing

Eurofins launched today globally Eurofins SAFER@WORK™, a suite of integrated risk-based solutions for businesses to keep staff and customers safer during the COVID-19 pandemic. The Eurofins SAFER@WORK programmes are designed to support businesses, looking to getting back to work or to ensure business continuity, to be able detect SARS-CoV-2 in their workplace as early as possible, and reduce … [Read more...] about Eurofins Launches Eurofins SAFER@WORK™: a Comprehensive Suite of Risk-Based COVID-19 Safety Solutions for Businesses

Eurofins Technologies announces the launch of its CE-IVD marked multiplex Real-Time RT-PCR (reverse-transcriptase polymerase chain reaction) assay for the direct qualitative pathogen detection of the novel coronavirus (SARS-CoV-2). Particularly in the early phase of COVID-19 infection, the direct and precise diagnostic of the pathogen is key. PCR is the method of choice to detect acute coronavirus … [Read more...] about Eurofins Technologies launches multiplex Real-Time PCR assay for SARS-CoV-2 (coronavirus) pathogen detection

From the onset of the COVID-19 crisis, Eurofins leadership’s priority has been to mobilise all available scientific talent and resources to help its clients and the world fight this terrible disease. Few companies in the world have so many and diverse scientific and technological capabilities to develop new solutions and services to combat the COVID-19 pandemic. Over 20 international … [Read more...] about Eurofins scientists develop multiple new solutions to support the world’s fight against the COVID-19 pandemic – ramping up production to enable over 20 million patients tests per month by end May 2020 Activity shows strong resilience in Q1 2020

In a continued effort to help fight the COVID-19 crisis, Eurofins Technologies announces the CE-IVD marking of a first range of testing kits for serology-based antibody detection by ELISA of patients who have been exposed to COVID-19. The development of the assays has been spearheaded by affiliate companies Gold Standard Diagnostics Inc., VIROTECH Diagnostics GmbH, NovaTec Immundiagnostica GmbH … [Read more...] about Eurofins Technologies launches multiple CE-IVD marked serologic products for the detection of antibodies in patients who have been exposed to SARS-CoV-2 (COVID-19)

Ebersberg, Germany - Eurofins Genomics Europe, a leader in genomic products and services, announces the launch of its “SARS-CoV-2 Full-length Genome Sequencing” service, a new next generation sequencing (NGS) service enabling end-to-end surveillance of the coronavirus genome sequence and mutational drift. The new service is Eurofins Genomics’ latest addition to a whole product portfolio aimed at … [Read more...] about Eurofins Genomics launches “SARS-CoV-2 Full-length Genome Sequencing” service to support researchers globally in their fight against the COVID-19 pandemic and outbreak source tracing

Viracor Eurofins received FDA EUA for its RT-PCR SARS-CoV-2 Virus LDT. Eurofins Genomics expands capacity for probes and primers production for RT-PCR SARS-CoV-2 test kits Eurofins Technologies, a fast growing provider of diagnostic technologies in the field of immunoassays and molecular detection methods, announces the launch of a range of testing kits for serology-based antibody detection by … [Read more...] about Eurofins Technologies launches multiple new products for the serologic detection of antibodies in patients who have been exposed to COVID-19

Eurofins, a global leader in testing and laboratory services, announces that its laboratories across the U.S.A., Europe and Asia are now providing a global service offer for testing, inspection and regulatory services focused on medical face masks, gloves and gowns, respiratory protective devices and equipment, its materials and components, as well as disinfectants and hand sanitizers, to serve … [Read more...] about Eurofins Scientific Offers a full range of Testing services for Personal Protective Equipment (PPEs) and Medical Devices used in the fight against the COVID pandemic

Eurofins Technologies, a fast growing provider of diagnostic technologies in the field of immunoassays and molecular detection methods, has launched GeneScan VIRSeek SARS-CoV-2 RT-PCR, an integrated solution including RNA extraction and test kits based on real-time RT-PCR (Reverse transcription polymerase chain reaction) for the detection of SARS-CoV-2 in swabs of environmental … [Read more...] about Eurofins Technologies launches testing solutions for the detection of SARS-CoV-2 on environmental surfaces

Eurofins, a global leader in testing and laboratory services, announces that, in addition to the U.S.A. and Germany, as previously communicated, it is now offering testing for detection of SARS-CoV-2 in France, Spain and Brazil with the Netherlands expected to start processing samples shortly. Global capacity created is currently around 10,000 tests per day split about equally between Europe and … [Read more...] about Eurofins Scientific Supports Healthcare Authorities in Europe, the U.S.A. and Brazil in their Fight against the COVID-19 Pandemic with Additional Testing Options and Fast Growing Capacity